Call Matthew 4
4 · iTeos Therapeutics, Inc. · Filed Mar 29, 2023
Insider Transaction Report
Form 4
Call Matthew
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2023-03-28−40,226→ 107,864 totalExercise: $2.95Exp: 2029-12-04→ Common Stock (40,226 underlying) - Exercise/Conversion
Common Stock
2023-03-28$2.95/sh+40,226$118,667→ 93,898 total
Footnotes (1)
- [F1]One-fourth of the shares subject to the stock option vest on the one-year anniversary of the vesting commencement date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date.